Plasmonic Lateral Flow Sensor for Ultrasensitive Pathogen Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional lateral flow immunoassays (LFIA) face challenges in achieving sensitive detection of pathogens due to weak colorimetric signals, which limits their effectiveness in food safety monitoring, and existing enhancement methods, such as enzyme-based amplification, are prone to nonspecific signals and stability issues.
Innovation Solution
A plasmonic enhancement strategy using gold nanoparticles (GNPs) and amine-containing chemical-loaded liposomes, where liposomes rupture to release branched polyethylenimine, facilitating GNP aggregation and generating a stronger colorimetric signal without the need for enzymes, allowing for ultrasensitive detection of pathogens like E. coli O157:H7 within 45 minutes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional colorimetric LFIA is used, then the method is simple and suitable for onsite usability, but the detection sensitivity is insufficient with LOD around 10^5-10^6 CFU/ml
Solution Approach 1:
The patent changes the physical-chemical parameters of the signal generation system by introducing plasmonic gold nanoparticles that undergo aggregation-induced color change. This transforms the detection mechanism from direct enzyme colorimetry to plasmonic signal amplification, achieving 1000-fold sensitivity improvement while maintaining lateral flow simplicity
Solution Approach 2:
The patent introduces liposomes as intermediary carriers that deliver amine-containing chemicals to trigger GNP aggregation. These liposomes act as mediators between the captured target and the signal amplification mechanism, enabling sensitive detection without direct enzyme involvement
2Measurement precision
If enzyme-based colorimetric signal amplification is used, then higher signal enhancement is achieved, but nonspecific signals and stability issues occur
Solution Approach 1:
The patent replaces the biochemical enzyme-catalyzed reaction system with a physical plasmonic aggregation system. Gold nanoparticles aggregate in response to amine-containing chemicals released from liposomes, producing color changes without enzymatic reactions. This eliminates enzyme-related nonspecific signals and stability problems while maintaining signal amplification capability
Solution Approach 2:
The patent changes the detection mechanism from biochemical (enzyme-based) to physicochemical (plasmonic aggregation). By utilizing the optical properties of gold nanoparticles and their aggregation-induced color change, the system achieves reliable signal enhancement without the limitations of enzyme-based methods
3Measurement precision
If liposome-based plasmonic ELISA is used, then single-digit pathogen detection is achieved, but the detection time is 3-4 hours
Solution Approach 1:
The patent segments the detection process into distinct functional zones on a lateral flow strip (sample application zone, detection zone, control zone). This spatial segmentation allows parallel processing and rapid results by enabling the sample to flow through multiple detection regions simultaneously, reducing total detection time to under 10 minutes
Solution Approach 2:
The patent uses the lateral flow membrane as an intermediary platform that facilitates rapid sample processing and signal generation. The membrane's capillary action and structured zones enable quick sample migration and concentrated signal development at the detection zone, achieving fast detection without sacrificing sensitivity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves a detection limit of 100 CFU/ml for E. coli O157:H7, which is over 1000 times more sensitive than conventional LFIA, and demonstrates versatility in detecting pathogens in liquid food samples, offering rapid and reliable onsite detection.
Implementation Method 1
A plasmonic enhancement strategy using gold nanoparticles (GNPs) and amine-containing chemical-loaded liposomes
Implementation Method 2
facilitating GNP aggregation and generating a stronger colorimetric signal
Implementation Method 3
where liposomes rupture to release branched polyethylenimine
Implementation Method 4
wherein the hydrolytic agent is capable of hydrolysis of said liposomes to release said amine-containing chemical
Implementation Method 5
a sample capture area having pre-loaded antibodies that are capable of binding a target analyte
Data Source
AI summary
The present disclosure relates to a novel method for lateral flow immunoassay (LFIA) by utilizing plasmonic enhancement strategy. More specifically, the present disclosure provides a plasmonic enhanced lateral flow sensor (pLFS) concept by introducing a liposome-based amplification of the colorimetric signals on the lateral flow platform for ultrasensitive detection of pathogens.